Jul 23, 2020
As the COVID-19 pandemic enters its 8th month, we continue to learn more about how SARS-CoV2 impacts our pediatric population, including the severe Kawasaki-like disease, Multisystem Inflammatory Syndrome in Children Associated with COVID-19, or MIS-C. In this, our 17th COVID-19 podcast we will cover the clinical presentation of MIS-C, how it differs from Kawasaki’s and what the early literature is saying. We are fortunate to be joined by two giants in the field of Pediatric Infectious Diseases: Jim Todd, MD and Mimi Glode, MD.
Dr. Glode is the former Section Head of Infectious Diseases at Children’s Colorado and is Professor Emerita of Pediatric Infectious Disease at the University of Colorado School of Medicine. Dr. Glode is an internationally recognized as an expert on Kawasaki disease and immunization pioneered the use of IVIG for the treatment for Kawasaki disease.
Dr. Todd is the former-Jules Amer Chair in Community Pediatrics and Section Head of Epidemiology at Children’s Hospital Colorado and Clinical Professor Emeritus in Pediatrics at the University of Colorado School of Medicine and is known for his discovery of Toxic Shock Syndrome.
What We Know About Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19
Do you have thoughts about today's episode or suggestions for a future topic? Write to us, firstname.lastname@example.org